Affordable Access

deepdyve-link
Publisher Website

Clinical testing for COVID-19.

Authors
  • Ward, Stephanie1
  • Lindsley, Andrew1
  • Courter, Josh2
  • Assa'ad, Amal3
  • 1 Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • 2 Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • 3 Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: [email protected]
Type
Published Article
Journal
The Journal of allergy and clinical immunology
Publication Date
Jul 01, 2020
Volume
146
Issue
1
Pages
23–34
Identifiers
DOI: 10.1016/j.jaci.2020.05.012
PMID: 32445839
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

As the novel coronavirus severe acute respiratory syndrome coronavirus 2 caused coronavirus disease 2019 cases in the United States, the initial test was developed and performed at the Centers for Disease Control and Prevention. As the number of cases increased, the demand for tests multiplied, leading the Centers for Disease Control and Prevention to use the Emergency Utilization Authorization to allow clinical and commercial laboratories to develop tests to detect the presence of the virus. Many nucleic acid tests based on RT-PCR were developed, each with different techniques, specifications, and turnaround time. As the illnesses turned into a pandemic, testing became more crucial. The test supply became inadequate to meet the need and so it had to be prioritized according to guidance. For surveillance, the need for serologic tests emerged. Here, we review the timeline of test development, the turnaround times, and the various approved tests, and compare them as regards the genes they detect. We concentrate on the point-of-care tests and discuss the basis for new serologic tests. We discuss the testing guidance for prioritization and their application in a hospital setting. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times